What are the negative effects does cytogain have?!
Question: What are the negative effects does cytogain have!?
I am looking into buying it but would like an opinion!.Www@Answer-Health@Com
Answers:
Check out "excess protein consumption" @
http://en!.wikipedia!.org/wiki/Protein_in_!.!.!.
You can also check out how your body metabolizes other ingredients in the supplement and if there are negative effects on excess intake @ www!.pubmed!.gov
!.!.!.of course this is not really specific to cytogain, but all protein supplements and weightgainersWww@Answer-Health@Com
http://en!.wikipedia!.org/wiki/Protein_in_!.!.!.
You can also check out how your body metabolizes other ingredients in the supplement and if there are negative effects on excess intake @ www!.pubmed!.gov
!.!.!.of course this is not really specific to cytogain, but all protein supplements and weightgainersWww@Answer-Health@Com
specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products!. The company currently has nine products on the market, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint(R) for imaging the extent and spread of prostate cancer, Quadramet(R) for the treatment of pain in patients whose cancer has spread to the bones, Erwinase(R) and Kidrolase(R) for the treatment of acute lymphoblastic leukemia, the antibiotic surgical implant Collatamp(R) G, and Rapydan(R), a rapid-onset anesthetic patch which recently received Europe-wide approval!. EUSA also has several products in late-stage development, notably Collatamp(R) G topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx(R) bupivacaine implant* for local post-surgical pain control!.
Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest!. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc!. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories!. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion!.Www@Answer-Health@Com
Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest!. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc!. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories!. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion!.Www@Answer-Health@Com